Free Trial

Pharvaris (PHVS) Financials

Pharvaris logo
$16.83 -1.83 (-9.81%)
Closing price 05/6/2025 04:00 PM Eastern
Extended Trading
$16.85 +0.02 (+0.12%)
As of 04:39 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Pharvaris

Annual Income Statements for Pharvaris

This table shows Pharvaris' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
-4.94 -9.01 -32 -48 -82 -112 -139
Consolidated Net Income / (Loss)
-4.94 -9.01 -32 -48 -82 -112 -139
Net Income / (Loss) Continuing Operations
-4.94 -9.01 -32 -48 -82 -112 -139
Total Pre-Tax Income
-4.94 -9.01 -32 -48 -81 -110 -137
Total Operating Income
-4.94 -8.99 -32 -48 -81 -110 -137
Total Gross Profit
-0.00 0.00 -1.30 13 12 -3.22 14
Total Revenue
0.00 0.00 -1.30 13 12 -3.22 14
Operating Revenue
- - -1.30 13 12 -3.22 14
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
4.94 8.99 31 61 93 107 151
Selling, General & Admin Expense
0.76 2.61 6.72 21 31 35 49
Research & Development Expense
4.17 6.38 24 41 61 73 102
Total Other Income / (Expense), net
0.00 -0.02 0.00 0.00 0.00 0.00 0.00
Income Tax Expense
0.00 0.00 -0.10 0.08 0.73 1.16 1.89
Basic Earnings per Share
($0.89) - ($5.36) ($1.40) ($2.27) ($2.63) ($2.57)
Weighted Average Basic Shares Outstanding
- - 4.85M 33.15M 33.82M 52.29M 54.38M
Diluted Earnings per Share
($0.89) - ($5.36) ($1.40) ($2.27) ($2.63) ($2.57)
Weighted Average Diluted Shares Outstanding
- - 4.85M 33.15M 33.82M 52.29M 54.38M
Weighted Average Basic & Diluted Shares Outstanding
- - 4.85M 33.15M 33.82M 52.29M 54.38M

Quarterly Income Statements for Pharvaris

No quarterly income statements for Pharvaris are available.


Annual Cash Flow Statements for Pharvaris

This table details how cash moves in and out of Pharvaris' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
0.68 17 97 112 -63 257 -122
Net Cash From Operating Activities
-4.48 -7.49 -26 -50 -72 -103 -124
Net Cash From Continuing Operating Activities
-4.66 -8.81 -29 -50 -79 -102 -129
Net Income / (Loss) Continuing Operations
-4.94 -9.01 -32 -48 -81 -110 -137
Consolidated Net Income / (Loss)
-4.94 -9.01 -32 -48 -81 -110 -137
Depreciation Expense
0.00 0.00 0.01 0.09 0.16 0.28 0.28
Non-Cash Adjustments To Reconcile Net Income
0.12 0.13 3.71 -4.07 0.11 14 6.33
Changes in Operating Assets and Liabilities, net
0.15 0.07 -0.64 2.01 1.83 -5.72 1.53
Net Cash From Investing Activities
0.00 -0.02 -0.05 -0.15 -0.13 -0.10 -0.56
Net Cash From Continuing Investing Activities
0.00 -0.02 -0.05 -0.15 -0.13 -0.10 -0.56
Purchase of Property, Plant & Equipment
0.00 -0.02 -0.05 -0.15 -0.13 -0.10 -0.56
Net Cash From Financing Activities
5.16 24 124 163 9.25 360 2.77
Net Cash From Continuing Financing Activities
5.16 24 124 -15 -1.03 -19 -0.17
Repayment of Debt
- - 0.00 0.00 -0.13 -0.24 -0.17

Quarterly Cash Flow Statements for Pharvaris

No quarterly cash flow statements for Pharvaris are available.


Annual Balance Sheets for Pharvaris

This table presents Pharvaris' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
23 124 240 179 441 302
Total Current Assets
23 123 239 178 440 300
Cash & Equivalents
23 120 237 173 433 291
Current Deferred & Refundable Income Taxes
- - - 0.41 1.15 3.05
Other Current Assets
0.05 2.14 1.71 4.95 6.17 5.95
Plant, Property, & Equipment, net
0.01 0.06 0.12 0.21 0.25 0.69
Plant, Property & Equipment, gross
0.01 0.06 0.12 0.21 0.25 0.69
Total Noncurrent Assets
0.00 0.00 0.47 0.74 0.69 1.33
Noncurrent Deferred & Refundable Income Taxes
- - 0.19 0.28 0.43 0.49
Other Noncurrent Operating Assets
- 0.00 0.28 0.46 0.26 0.84
Total Liabilities & Shareholders' Equity
23 124 240 179 441 302
Total Liabilities
2.16 6.49 8.08 20 16 24
Total Current Liabilities
2.16 6.47 7.76 19 16 23
Accounts Payable
0.58 1.01 2.82 7.15 3.22 4.72
Accrued Expenses
1.58 5.46 4.83 12 12 18
Other Current Liabilities
- 0.00 0.11 0.20 0.22 0.23
Total Noncurrent Liabilities
0.00 0.00 0.17 0.27 0.05 0.66
Capital Lease Obligations
- - 0.17 0.27 0.05 0.66
Total Equity & Noncontrolling Interests
21 117 232 160 425 277
Total Preferred & Common Equity
21 117 232 160 425 277
Preferred Stock
41 169 315 309 681 646
Total Common Equity
-20 -52 -84 -150 -256 -368
Common Stock
0.15 0.29 4.50 4.34 6.94 6.75
Retained Earnings
-21 -54 -99 -176 -294 -416
Other Equity Adjustments
0.44 2.41 11 22 31 41

Quarterly Balance Sheets for Pharvaris

No quarterly balance sheets for Pharvaris are available.


Annual Metrics and Ratios for Pharvaris

This table displays calculated financial ratios and metrics derived from Pharvaris' official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 1,100.99% -8.91% -127.23% 527.01%
EBITDA Growth
0.00% -82.45% -253.43% -51.38% -67.59% -36.37% -24.17%
EBIT Growth
0.00% -82.46% -253.51% -51.62% -67.62% -36.44% -24.10%
NOPAT Growth
0.00% -82.07% -254.25% -51.62% -67.62% -36.44% -24.10%
Net Income Growth
0.00% -82.46% -252.38% -52.35% -68.85% -36.65% -24.51%
EPS Growth
0.00% 0.00% 0.00% 73.88% -62.14% -15.86% 11.77%
Operating Cash Flow Growth
0.00% -67.08% -250.50% -92.19% -42.34% -43.26% -20.81%
Free Cash Flow Firm Growth
0.00% 0.00% -363.57% -58.98% -48.67% -69.82% -10.46%
Invested Capital Growth
0.00% 0.00% -92.72% -30.54% -172.06% 41.54% -63.54%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - -
Gross Margin
0.00% 0.00% 0.00% 100.00% 100.00% 0.00% 100.00%
EBITDA Margin
0.00% 0.00% 0.00% -371.00% -682.57% 0.00% -994.06%
Operating Margin
0.00% 0.00% 0.00% -371.67% -683.96% 0.00% -996.09%
EBIT Margin
0.00% 0.00% 0.00% -371.67% -683.96% 0.00% -996.09%
Profit (Net Income) Margin
0.00% 0.00% 0.00% -372.29% -690.10% 0.00% -1,009.82%
Tax Burden Percent
100.00% 100.00% 99.68% 100.16% 100.90% 101.05% 101.38%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -42.99% -46.02% -27.72% -41.70% -38.18% -39.58%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% -26.56% -38.59% 0.00% -36.91%
Return on Assets (ROA)
0.00% 0.00% 0.00% -26.61% -38.93% 0.00% -37.42%
Return on Common Equity (ROCE)
0.00% 41.32% 23.93% 10.73% 24.83% 26.52% 35.23%
Return on Equity Simple (ROE_SIMPLE)
0.00% -42.99% -27.13% -20.85% -51.14% -26.27% -50.13%
Net Operating Profit after Tax (NOPAT)
-3.46 -6.29 -22 -34 -57 -77 -96
NOPAT Margin
0.00% 0.00% 0.00% -260.17% -478.77% 0.00% -697.26%
Net Nonoperating Expense Percent (NNEP)
0.00% -23.81% -13.18% -8.15% -12.23% -11.34% -11.92%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - -34.53%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 159.87% 265.24% 0.00% 354.54%
R&D to Revenue
0.00% 0.00% 0.00% 311.81% 518.71% 0.00% 741.54%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 471.67% 783.96% 0.00% 1,096.09%
Earnings before Interest and Taxes (EBIT)
-4.94 -9.01 -32 -48 -81 -110 -137
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-4.94 -9.01 -32 -48 -81 -110 -137
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 5.37 31.52 0.00 72.86
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 11.43 43.05 0.00 98.71
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -1.09 -1.04 -1.02 -1.04 -1.03 -1.03
Leverage Ratio
0.00 1.10 1.06 1.04 1.07 1.06 1.06
Compound Leverage Factor
0.00 1.10 1.06 1.04 1.07 1.06 1.06
Debt to Total Capital
0.00% 0.00% 0.00% 0.07% 0.17% 0.01% 0.24%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.07% 0.17% 0.01% 0.24%
Preferred Equity to Total Capital
0.00% 196.13% 144.11% 135.90% 193.42% 160.33% 232.36%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -96.13% -44.11% -35.98% -93.59% -60.34% -132.59%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 4.91 2.14 3.93 2.12
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 -0.01 0.00 0.00 -0.01
Net Debt to NOPAT
0.00 0.00 0.00 7.01 3.05 5.60 3.02
Long-Term Debt to NOPAT
0.00 0.00 0.00 -0.01 0.00 0.00 -0.01
Altman Z-Score
0.00 44.51 14.95 5.15 9.60 34.52 22.32
Noncontrolling Interest Sharing Ratio
0.00% 196.13% 152.01% 138.72% 159.54% 169.47% 189.00%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 10.70 19.06 30.84 9.39 28.07 12.94
Quick Ratio
0.00 10.67 18.72 30.62 9.11 27.60 12.55
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -4.44 -21 -33 -49 -83 -91
Operating Cash Flow to CapEx
0.00% -49,546.04% -50,025.73% -34,299.06% -54,034.37% -103,406.58% -22,325.46%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.00 0.00 0.07 0.06 0.00 0.04
Accounts Receivable Turnover
0.00 0.00 0.00 17.46 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 143.07 71.86 0.00 29.34
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 20.91 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 20.91 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 -1.85 -3.57 -4.67 -13 -7.42 -12
Invested Capital Turnover
0.00 0.00 0.00 -3.15 -1.36 0.00 -1.41
Increase / (Decrease) in Invested Capital
0.00 -1.85 -1.72 -1.09 -8.03 5.27 -4.72
Enterprise Value (EV)
0.00 184 214 148 509 1,197 1,358
Market Capitalization
165 165 165 70 373 949 1,002
Book Value per Share
$0.00 ($2.44) ($10.64) ($17.22) ($4.52) ($7.58) ($7.04)
Tangible Book Value per Share
$0.00 ($2.44) ($10.64) ($17.22) ($4.52) ($7.58) ($7.04)
Total Capital
0.00 21 117 232 160 425 278
Total Debt
0.00 0.00 0.00 0.17 0.27 0.05 0.66
Total Long-Term Debt
0.00 0.00 0.00 0.17 0.27 0.05 0.66
Net Debt
0.00 -23 -120 -237 -173 -433 -290
Capital Expenditures (CapEx)
0.00 0.02 0.05 0.15 0.13 0.10 0.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -1.87 -3.63 -5.26 -14 -8.35 -14
Debt-free Net Working Capital (DFNWC)
0.00 21 117 232 159 424 276
Net Working Capital (NWC)
0.00 21 117 232 159 424 276
Net Nonoperating Expense (NNE)
1.48 2.72 9.45 15 25 34 43
Net Nonoperating Obligations (NNO)
0.00 -23 -121 -237 -172 -432 -289
Total Depreciation and Amortization (D&A)
0.00 0.00 0.01 0.09 0.16 0.28 0.28
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% -40.48% -115.30% 0.00% -102.94%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 1,783.47% 1,347.81% 0.00% 2,009.12%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 1,783.47% 1,347.81% 0.00% 2,009.12%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($5.36) $0.00 ($2.27) ($2.63) ($2.57)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 4.85M 33.15M 33.82M 52.29M 54.38M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($5.36) $0.00 ($2.27) ($2.63) ($2.57)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 4.85M 33.15M 33.82M 52.29M 54.38M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($5.36) $0.00 ($2.27) $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 4.85M 33.15M 33.82M 52.29M 54.38M
Normalized Net Operating Profit after Tax (NOPAT)
-3.46 -6.29 -22 -34 -57 -77 -96
Normalized NOPAT Margin
0.00% 0.00% 0.00% -260.17% -478.77% 0.00% -697.26%
Pre Tax Income Margin
0.00% 0.00% 0.00% -371.67% -683.96% 0.00% -996.09%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -10.42% -5.06% -30.78% -1.10% -17.15% 0.00%

Quarterly Metrics and Ratios for Pharvaris

No quarterly metrics and ratios for Pharvaris are available.


Frequently Asked Questions About Pharvaris' Financials

When does Pharvaris's fiscal year end?

According to the most recent income statement we have on file, Pharvaris' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Pharvaris' net income changed over the last 6 years?

Pharvaris' net income appears to be on an upward trend, with a most recent value of -$138.93 million in 2024, rising from -$4.94 million in 2018. The previous period was -$111.59 million in 2023. See Pharvaris' forecast for analyst expectations on what’s next for the company.

What is Pharvaris's operating income?
Pharvaris's total operating income in 2024 was -$137.04 million, based on the following breakdown:
  • Total Gross Profit: $13.76 million
  • Total Operating Expenses: $150.80 million
How has Pharvaris revenue changed over the last 6 years?

Over the last 6 years, Pharvaris' total revenue changed from $0.00 in 2018 to $13.76 million in 2024, a change of 1,375,820,100.0%.

How much debt does Pharvaris have?

Pharvaris' total liabilities were at $24.44 million at the end of 2024, a 50.9% increase from 2023, and a 1,031.9% increase since 2019.

How much cash does Pharvaris have?

In the past 5 years, Pharvaris' cash and equivalents has ranged from $22.81 million in 2019 to $432.78 million in 2023, and is currently $290.58 million as of their latest financial filing in 2024.

How has Pharvaris' book value per share changed over the last 6 years?

Over the last 6 years, Pharvaris' book value per share changed from 0.00 in 2018 to -7.04 in 2024, a change of -704.5%.



This page (NASDAQ:PHVS) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners